InvestorsHub Logo
Followers 132
Posts 6427
Boards Moderated 0
Alias Born 05/13/2014

Re: Curt D post# 24514

Thursday, 10/01/2020 9:36:16 PM

Thursday, October 01, 2020 9:36:16 PM

Post# of 44690
That’s right. Only one I was apart of was ANAC. If my memory serves, they were QB and went to Nasdaq, ran up to $60 or thereabouts and got bought at over $90 by Pfizer, $5bln valuation.... I had it at $9 in 2010 or 2011.... going back a bit ... it dumped hard and might have even lost Nasdaq status for a bit ... can’t remember if it restructured to maintain compliance.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire_anacor

I think we could see it here Curt D. Could happen from QB for sure.... I think it’ll fetch a better valuation on the Nasdaq.... wouldn’t mind seeing it up around $5bln and get bought for $10bln .... At $1.2bln we’re still a little baby !!!

Also we gotta remember all the EU stuff they’re doing , and Israel ... and not just the US rollout.

Anywhooooo .... my .02 !!! Time for a vodka-valium-spritzer-super-smoker cocktail ;)

$RLFTF

I love how folks talk about the “huge outstanding share count” as if it makes a difference on something like this. I forget but ANAC might’ve even restructured to maintain compliance before uplist. Anyway .... it was either gonna be Allergan or Anacor for Pfizer .... Allergan had a $160billion price tag.

Covid treatment going through trials &